Impact of neoadjuvant therapy on gut microbiome in patients with resectable/borderline resectable pancreatic ductal adenocarcinoma.
Takaori A, Hashimoto D, Ikeura T, Ito T, Nakamaru K, Masuda M, Nakayama S, Yamaki S, Yamamoto T, Fujimoto K, Matsuo Y, Akagawa S, Ishida M, Yamaguchi K, Imoto S, Hirota K, Uematsu S, Satoi S, Sekimoto M, Naganuma M.
Takaori A, et al. Among authors: naganuma m.
Pancreatology. 2023 Jun;23(4):367-376. doi: 10.1016/j.pan.2023.04.001. Epub 2023 Apr 5.
Pancreatology. 2023.
PMID: 37088586